Skip to main content
Signal8

Connealy Pamela Ann

SEC insider (Form 3/4/5 filer). CIK 0001796310. Director at Orchestra BioMed Holdings, Inc. (OBIO) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 23, 2026. Located in NEW HOPE, PA.

Companies Connealy Pamela Ann has filed insider reports for

  • Orchestra BioMed Holdings, Inc. (OBIO): Director
  • Pyxis Oncology, Inc. (PYXS): Officer, CFO & COO
Connealy Pamela Ann profile photo

Connealy Pamela Ann

CIK: 0001796310

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Orchestra BioMed Holdings, Inc. logo
OBIO

Orchestra BioMed Holdings, Inc.

Director
Pyxis Oncology, Inc. logo
PYXS

Pyxis Oncology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Orchestra BioMed Holdings, Inc. logo
    OBIO

    Orchestra BioMed Holdings, Inc.

    Jun 23, 2026
    Award
    Direct
    17.3K shares-
  • Orchestra BioMed Holdings, Inc. logo
    OBIO

    Orchestra BioMed Holdings, Inc.

    Aug 7, 2025
    Award
    Direct
    15K shares-
  • Orchestra BioMed Holdings, Inc. logo
    OBIO

    Orchestra BioMed Holdings, Inc.

    Jun 24, 2025
    Award
    Direct
    12.4K shares-
  • Pyxis Oncology, Inc. logo
    PYXS

    Pyxis Oncology, Inc.

    Mar 31, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    414.2K shares at avg. $0.98-
  • Pyxis Oncology, Inc. logo
    PYXS

    Pyxis Oncology, Inc.

    Dec 23, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    310K shares-
  • Pyxis Oncology, Inc. logo
    PYXS

    Pyxis Oncology, Inc.

    Nov 26, 2024
    Purchase
    Indirect
    5.5K shares at avg. $2.00$11K
  • Pyxis Oncology, Inc. logo
    PYXS

    Pyxis Oncology, Inc.

    Nov 26, 2024
    Purchase
    Indirect
    83.4K shares at avg. $1.96$163K

1-7 of 7